Literature DB >> 12007175

Synthesis of ferroquine enantiomers: first investigation of effects of metallocenic chirality upon antimalarial activity and cytotoxicity.

Laurence Delhaes1, Christophe Biot, Laurence Berry, Philippe Delcourt, Lucien A Maciejewski, Daniel Camus, Jacques S Brocard, Daniel Dive.   

Abstract

Ferroquine (FQ) is a new antimalarial agent with a high blood schizotoncidal activity. Previous studies on this compound were done with racemate mixtures. As FQ possesses planar chirality, pure enantiomers were obtained by enzymatic resolution in order to compare their antimalarial activities and cytotoxicities. (+)-FQ and (-)-FQ were equally active in vitro, at nanomolar concentrations. Both enantiomers were slightly less active than the racemate in vivo; cytotoxicities were similar. Actually, the racemate represents the optimal formulation. To the best of our knowledge, this is the first investigation of biological activities of compounds with metallocenic chirality.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12007175     DOI: 10.1002/1439-7633(20020503)3:5<418::AID-CBIC418>3.0.CO;2-P

Source DB:  PubMed          Journal:  Chembiochem        ISSN: 1439-4227            Impact factor:   3.164


  9 in total

1.  Inhibitory activity of ferroquine, versus chloroquine, against western Kenya Plasmodium falciparum field isolates determined by a SYBR Green I in vitro assay.

Authors:  Fredrick L Eyase; Hoseah M Akala; Jacob D Johnson; Douglas S Walsh
Journal:  Am J Trop Med Hyg       Date:  2011-12       Impact factor: 2.345

2.  Ex vivo drug susceptibility of ferroquine against chloroquine-resistant isolates of Plasmodium falciparum and P. vivax.

Authors:  Jutta Marfurt; Ferryanto Chalfein; Pak Prayoga; Frans Wabiser; Enny Kenangalem; Kim A Piera; Barbara Machunter; Emiliana Tjitra; Nicholas M Anstey; Ric N Price
Journal:  Antimicrob Agents Chemother       Date:  2011-07-05       Impact factor: 5.191

3.  Antimalarial activity of thiophenyl- and benzenesulfonyl-dihydroartemisinin.

Authors:  Seokjoon Lee; Sangtae Oh; Gab-Man Park; Tong-Soo Kim; Jae-Sook Ryu; Han-Kyu Choi
Journal:  Korean J Parasitol       Date:  2005-09       Impact factor: 1.341

Review 4.  The antimalarial ferroquine: from bench to clinic.

Authors:  C Biot; F Nosten; L Fraisse; D Ter-Minassian; J Khalife; D Dive
Journal:  Parasite       Date:  2011-08       Impact factor: 3.000

5.  Antimalarial Activity of C-10 Substituted Triazolyl Artemisinin.

Authors:  Gab-Man Park; Hyun Park; Sangtae Oh; Seokjoon Lee
Journal:  Korean J Parasitol       Date:  2017-12-31       Impact factor: 1.341

6.  Enantiomeric-Enriched Ferrocenes: Synthesis, Chiral Resolution, and Mathematic Evaluation of CD-chiral Selector Energies with Ferrocene-Conjugates.

Authors:  Lubov V Snegur; Yurii A Borisov; Yuliya V Kuzmenko; Vadim A Davankov; Mikhail M Ilyin; Mikhail M Ilyin; Dmitry E Arhipov; Alexander A Korlyukov; Sergey S Kiselev; Alexander A Simenel
Journal:  Molecules       Date:  2017-08-25       Impact factor: 4.411

Review 7.  Ferroquine and its derivatives: new generation of antimalarial agents.

Authors:  Waseem A Wani; Ehtesham Jameel; Umair Baig; Syed Mumtazuddin; Lee Ting Hun
Journal:  Eur J Med Chem       Date:  2015-07-08       Impact factor: 6.514

8.  Assessment of Plasmodium falciparum resistance to ferroquine (SSR97193) in field isolates and in W2 strain under pressure.

Authors:  Wassim Daher; Christophe Biot; Thierry Fandeur; Helene Jouin; Lydie Pelinski; Eric Viscogliosi; Laurent Fraisse; Bruno Pradines; Jacques Brocard; Jamal Khalife; Daniel Dive
Journal:  Malar J       Date:  2006-02-07       Impact factor: 2.979

Review 9.  Ferrocene conjugates of chloroquine and other antimalarials: the development of ferroquine, a new antimalarial.

Authors:  Daniel Dive; Christophe Biot
Journal:  ChemMedChem       Date:  2008-03       Impact factor: 3.466

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.